Delighted to share that our complementary paper to the BPZE1 vaccine trial is now out, featuring an in‑depth analysis of immune responses associated with protection. lnkd.in/ekqr2FYD
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn